CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Volume 16 Issue 1

Navigating the 2024 Life Science Landscape: Trends, Challenges, and Opportunities

As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. ...
Continue Reading →
Volume 16 Issue 1

Novel Drugs: Challenging Entrenched Prescriber/Investment Behaviour is not Just About Education

Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Drawing on examples ...
Continue Reading →
Volume 16 Issue 1

The End to Painfully Slow Cloud Migration?

Despite the benefits of moving to the cloud, migration can still be prohibitively time-consuming and costly, especially in a highly regulated industry like pharma. B...
Continue Reading →
Volume 16 Issue 1

The Future of Sterility

Advancements and Innovations in Sterile Drug Product Manufacturing Sterile drug product manufacturing is complex and plays a crucial role in the pharmaceutical in...
Continue Reading →
Volume 15 Issue 4

Print Quality Control Throughout the Production Process

IPI speaks with Dr. Andre Schwarz of EyeC GmbH about how Pharmaceuticals and medicaldevices require flawless printing of essential information Q: EyeC is the only...
Continue Reading →
Volume 15 Issue 4

The Trial Master File (TMF)

IPI speaks with Aaron Grant, VP of Solutions Consulting at Phlexglobal, (a PharmaLex Company)on how managing the TMF requires following best practice and taking adva...
Continue Reading →
Volume 15 Issue 4

What is the Right Validation Model? Practical Considerations and Applications

It is now widely accepted that validation in the life sciences industry follows a lifecycle model.1,2 What is not always clear is the specific model – or models – to...
Continue Reading →
Volume 15 Issue 4

Understanding and Working Towards Container Closure Integrity

Primum non nocere. First, do no harm. This sentence, often considered as the official motto of healthcare providers, organisations, and associations around the wo...
Continue Reading →
Volume 15 Issue 4

Ensuring the World’s Access to Vital Medicine: The Role of the Cargo Industry in Pharmaceutical Transport

During the global pandemic, the importance of transporting vital vaccines and medicines was brought sharply into the spotlight. COVID-19 amplified just how important...
Continue Reading →
Volume 15 Issue 3

Why Pharma Dealmaking is a Sector that’s Ripe for Growth

The global pharmaceutical sector is booming thanks to continued growth in R&D spend in new technologies and therapeutic areas, putting the industry back on a mor...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026